Barclays
UAMY icon

Barclays’s United States Antimony UAMY Stock Holding History

Barclays’s Portfolio UAMY Stock Details UAMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$342K Sell
47,149
-115,334
-71% -$1.04M ﹤0.01% 3421
2026
Q1 		$1.42M Sell
162,483
-58,816
-27% -$513K ﹤0.01% 2547
2025
Q4 		$1.11M Buy
221,299
+64,517
+41% +$507K ﹤0.01% 3357
2025
Q3 		$972K Sell
156,782
-214,432
-58% -$896K ﹤0.01% 3383
2025
Q2 		$809K Buy
+371,214
New +$1.05M ﹤0.01% 3476
2022
Q2 		– Sell
-1,201
Closed -$1K – 5277
2022
Q1 		$1K Hold
1,201
– – ﹤0.01% 4854
2021
Q4 		$1K Hold
1,201
– – ﹤0.01% 4081
2021
Q3 		$1K Hold
1,201
– – ﹤0.01% 4713
2021
Q2 		$1K Sell
1,201
-603
-33% -$559 ﹤0.01% 4838
2021
Q1 		$2K Buy
1,804
+603
+50% +$673 ﹤0.01% 4570
2020
Q4 		$1K Buy
+1,201
New +$488 ﹤0.01% 4832
2020
Q3 		– Sell
-3
Closed – – 5594
2020
Q2 		$0 Buy
+3
New +$1 ﹤0.01% 6248
2013
Q3 		– Sell
-107,122
Closed -$119K – 7620
2013
Q2 		$119K Buy
+107,122
New +$146K ﹤0.01% 5647

Other funds holding UAMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Barclays's UAMY Position: Q2 2026 in Review

Barclays reduced its United States Antimony (UAMY) stake by 71% in Q2 2026, selling an estimated $1.04M and leaving 47,149 shares worth $342K. The position accounts for ﹤0.01% of the portfolio, ranked #3421.

Barclays first reported a position in UAMY in Q2 2013 and has held it in 13 quarters since. The position peaked at $1.42M in Q1 2026. 240 funds tracked by Wall St. Rank hold UAMY as of Q2 2026.

  • Barclays held 47,149 shares of United States Antimony worth $342K as of Q2 2026.
  • Barclays sold 115,334 United States Antimony shares in Q2 2026, an estimated $1.04M.
  • United States Antimony made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3421 holding.
  • Barclays first reported a position in United States Antimony in Q2 2013 and has held it in 13 quarters since.
  • Barclays's United States Antimony position peaked at $1.42M in Q1 2026.
  • 240 funds tracked by Wall St. Rank held United States Antimony as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.